Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
More than just multiple sclerosis.
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
Novel Agents for Relapsing Forms of Multiple Sclerosis.
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Increased Th17 response to myelin peptides in pediatric MS.
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis.
Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study.
Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
Benefits of whole-body vibration with an oscillating platform for people with multiple sclerosis: a systematic review.
Health beliefs and physical activity behavior in adults with multiple sclerosis.
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Identification of a unique TGF-β-dependent molecular and functional signature in microglia.
Effect of the time of day on central and peripheral fatigue during 2-min maximal voluntary contractions in persons with multiple sclerosis: gender differences.
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis.
Sodium channels in astroglia and microglia.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Pages
« first
‹ previous
…
298
299
300
301
302
303
304
305
306
…
next ›
last »